Delia A. Deschaine

ID: 1b83f8ef-2619-30fb-68c4

/

Unclaimed

/

Organization: Epstein Becker & Green, P.C.

FDA Issues Orphan Drug Exclusivity Policy That Could Be a Catalyst for Future Litigation

Health Care and Life Sciences · January 31, 2023

Recent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products

Cannabis · May 19, 2022

DEA Finalizes Rule Requiring All Registrations and Renewal Applications to Be Completed Online

Health Care and Life Sciences · April 13, 2022

Deadline Looms for Responding to DEA’s Proposed Aggregate Production Quotas for 2021

Health Care and Life Sciences · September 25, 2020

FDA Issues Draft Guidance on Cannabis Clinical Research and Sends CBD Enforcement Discretion Guidance to OMB for Review

Food, Drug & Agriculture · July 28, 2020